These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 28003306)

  • 61. Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk
    Wei JS; Kuznetsov IB; Zhang S; Song YK; Asgharzadeh S; Sindiri S; Wen X; Patidar R; Najaraj S; Walton A; Auvil JMG; Gerhard DS; Yuksel A; Catchpoole D; Hewitt SM; Sondel PM; Seeger R; Maris JM; Khan J
    Clin Cancer Res; 2018 Nov; 24(22):5673-5684. PubMed ID: 29784674
    [No Abstract]   [Full Text] [Related]  

  • 62. SMARCE1 promotes neuroblastoma tumorigenesis through assisting MYCN-mediated transcriptional activation.
    Hu X; Liu R; Hou J; Peng W; Wan S; Xu M; Li Y; Zhang G; Zhai X; Liang P; Cui H
    Oncogene; 2022 Sep; 41(37):4295-4306. PubMed ID: 35978151
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors.
    Mestdagh P; Fredlund E; Pattyn F; Schulte JH; Muth D; Vermeulen J; Kumps C; Schlierf S; De Preter K; Van Roy N; Noguera R; Laureys G; Schramm A; Eggert A; Westermann F; Speleman F; Vandesompele J
    Oncogene; 2010 Mar; 29(9):1394-404. PubMed ID: 19946337
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation.
    Le Grand M; Mukha A; Püschel J; Valli E; Kamili A; Vittorio O; Dubrovska A; Kavallaris M
    Theranostics; 2020; 10(14):6411-6429. PubMed ID: 32483461
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma.
    Sahu D; Hsu CL; Lin CC; Yang TW; Hsu WM; Ho SY; Juan HF; Huang HC
    Oncotarget; 2016 Sep; 7(36):58022-58037. PubMed ID: 27517149
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastoma.
    Lau DT; Flemming CL; Gherardi S; Perini G; Oberthuer A; Fischer M; Juraeva D; Brors B; Xue C; Norris MD; Marshall GM; Haber M; Fletcher JI; Ashton LJ
    Oncotarget; 2015 Jun; 6(17):15510-23. PubMed ID: 25860940
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MicroRNA-145 overexpression inhibits neuroblastoma tumorigenesis
    Zhao J; Zhou K; Ma L; Zhang H
    Bioengineered; 2020 Dec; 11(1):219-228. PubMed ID: 32083506
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MCPIP1 Exogenous Overexpression Inhibits Pathways Regulating MYCN Oncoprotein Stability in Neuroblastoma.
    Boratyn E; Nowak I; Durbas M; Horwacik I; Sawicka A; Rokita H
    J Cell Biochem; 2017 Jul; 118(7):1741-1755. PubMed ID: 27935099
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line.
    Chevrier L; Meunier AC; Cochaud S; Muller JM; Chadéneau C
    Int J Oncol; 2008 Nov; 33(5):1081-9. PubMed ID: 18949372
    [TBL] [Abstract][Full Text] [Related]  

  • 70. SGO1 is involved in the DNA damage response in MYCN-amplified neuroblastoma cells.
    Murakami-Tonami Y; Ikeda H; Yamagishi R; Inayoshi M; Inagaki S; Kishida S; Komata Y; Jan Koster ; Takeuchi I; Kondo Y; Maeda T; Sekido Y; Murakami H; Kadomatsu K
    Sci Rep; 2016 Aug; 6():31615. PubMed ID: 27539729
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Deficiency of BAP1 inhibits neuroblastoma tumorigenesis through destabilization of MYCN.
    Zhang X; Cong X; Jin X; Liu Y; Zhang T; Fan X; Shi X; Zhang X; Wang X; Yang YG; Dai X
    Cell Death Dis; 2023 Aug; 14(8):504. PubMed ID: 37543638
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response.
    Petroni M; Veschi V; Prodosmo A; Rinaldo C; Massimi I; Carbonari M; Dominici C; McDowell HP; Rinaldi C; Screpanti I; Frati L; Bartolazzi A; Gulino A; Soddu S; Giannini G
    Mol Cancer Res; 2011 Jan; 9(1):67-77. PubMed ID: 21173028
    [TBL] [Abstract][Full Text] [Related]  

  • 73. MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes.
    Soriano A; París-Coderch L; Jubierre L; Martínez A; Zhou X; Piskareva O; Bray I; Vidal I; Almazán-Moga A; Molist C; Roma J; Bayascas JR; Casanovas O; Stallings RL; Sánchez de Toledo J; Gallego S; Segura MF
    Oncotarget; 2016 Feb; 7(8):9271-87. PubMed ID: 26824183
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Quantitative Proteomics of Th-MYCN Transgenic Mice Reveals Aurora Kinase Inhibitor Altered Metabolic Pathways and Enhanced ACADM To Suppress Neuroblastoma Progression.
    Hsieh CH; Cheung CHY; Liu YL; Hou CL; Hsu CL; Huang CT; Yang TS; Chen SF; Chen CN; Hsu WM; Huang HC; Juan HF
    J Proteome Res; 2019 Nov; 18(11):3850-3866. PubMed ID: 31560547
    [TBL] [Abstract][Full Text] [Related]  

  • 75. TAp63 represses transcription of MYCN/NCYM gene and its high levels of expression are associated with favorable outcome in neuroblastoma.
    Suenaga Y; Yamamoto M; Sakuma T; Sasada M; Fukai F; Ohira M; Yamaguchi Y; Yamamoto T; Ando K; Ozaki T; Nakagawara A
    Biochem Biophys Res Commun; 2019 Oct; 518(2):311-318. PubMed ID: 31427086
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    De Rosa P; Severi F; Zadran SK; Russo M; Aloisi S; Rigamonti A; Capranico G; Milazzo G; Perini G
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982482
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neuroblastoma-derived v-myc avian myelocytomatosis viral related oncogene or
    Bhardwaj N; Das G; Srinivasan R
    J Clin Pathol; 2023 Aug; 76(8):518-523. PubMed ID: 37221048
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MiR-181a/b induce the growth, invasion, and metastasis of neuroblastoma cells through targeting ABI1.
    Liu X; Peng H; Liao W; Luo A; Cai M; He J; Zhang X; Luo Z; Jiang H; Xu L
    Mol Carcinog; 2018 Sep; 57(9):1237-1250. PubMed ID: 29802737
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MCPIP1 ribonuclease can bind and cleave
    Nowak I; Boratyn E; Student S; Bernhart SF; Fallmann J; Durbas M; Stadler PF; Rokita H
    RNA Biol; 2021 Jan; 18(1):144-156. PubMed ID: 32757706
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastoma.
    De Brouwer S; Mestdagh P; Lambertz I; Pattyn F; De Paepe A; Westermann F; Schroeder C; Schulte JH; Schramm A; De Preter K; Vandesompele J; Speleman F
    Int J Cancer; 2012 Jun; 130(11):2591-8. PubMed ID: 21796614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.